UBS Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-39,027
| Closed | -$3.98M | – | 8927 |
|
2023
Q2 | $3.98M | Buy |
39,027
+21,283
| +120% | +$2.17M | ﹤0.01% | 2090 |
|
2023
Q1 | $1.61M | Buy |
17,744
+15,259
| +614% | +$1.39M | ﹤0.01% | 2783 |
|
2022
Q4 | $94.4K | Sell |
2,485
-1,273
| -34% | -$48.4K | ﹤0.01% | 5039 |
|
2022
Q3 | $94K | Buy |
3,758
+1,200
| +47% | +$30K | ﹤0.01% | 4709 |
|
2022
Q2 | $78K | Buy |
2,558
+759
| +42% | +$23.1K | ﹤0.01% | 4607 |
|
2022
Q1 | $59K | Sell |
1,799
-1,759
| -49% | -$57.7K | ﹤0.01% | 5323 |
|
2021
Q4 | $93K | Sell |
3,558
-2,614
| -42% | -$68.3K | ﹤0.01% | 5305 |
|
2021
Q3 | $621K | Sell |
6,172
-1,207
| -16% | -$121K | ﹤0.01% | 3587 |
|
2021
Q2 | $1.04M | Buy |
7,379
+875
| +13% | +$124K | ﹤0.01% | 3214 |
|
2021
Q1 | $648K | Sell |
6,504
-9,333
| -59% | -$930K | ﹤0.01% | 3739 |
|
2020
Q4 | $1.96M | Sell |
15,837
-23,506
| -60% | -$2.9M | ﹤0.01% | 2649 |
|
2020
Q3 | $3.83M | Buy |
39,343
+28,122
| +251% | +$2.74M | ﹤0.01% | 1905 |
|
2020
Q2 | $1.75M | Buy |
11,221
+8,060
| +255% | +$1.26M | ﹤0.01% | 2380 |
|
2020
Q1 | $456K | Sell |
3,161
-12,375
| -80% | -$1.79M | ﹤0.01% | 3296 |
|
2019
Q4 | $3.18M | Buy |
15,536
+9,581
| +161% | +$1.96M | ﹤0.01% | 2378 |
|
2019
Q3 | $479K | Sell |
5,955
-783
| -12% | -$63K | ﹤0.01% | 3764 |
|
2019
Q2 | $636K | Sell |
6,738
-21,483
| -76% | -$2.03M | ﹤0.01% | 3376 |
|
2019
Q1 | $2.41M | Buy |
28,221
+738
| +3% | +$63.1K | ﹤0.01% | 2296 |
|
2018
Q4 | $1.54M | Buy |
27,483
+959
| +4% | +$53.8K | ﹤0.01% | 2653 |
|
2018
Q3 | $2.17M | Sell |
26,524
-8,521
| -24% | -$697K | ﹤0.01% | 2553 |
|
2018
Q2 | $1.23M | Buy |
35,045
+15,112
| +76% | +$529K | ﹤0.01% | 2908 |
|
2018
Q1 | $409K | Buy |
19,933
+16,458
| +474% | +$338K | ﹤0.01% | 3586 |
|
2017
Q4 | $99K | Buy |
3,475
+1,110
| +47% | +$31.6K | ﹤0.01% | 4427 |
|
2017
Q3 | $73K | Sell |
2,365
-967
| -29% | -$29.8K | ﹤0.01% | 4659 |
|
2017
Q2 | $105K | Buy |
3,332
+2,109
| +172% | +$66.5K | ﹤0.01% | 4260 |
|
2017
Q1 | $27K | Sell |
1,223
-1,265
| -51% | -$27.9K | ﹤0.01% | 5033 |
|
2016
Q4 | $54K | Buy |
+2,488
| New | +$54K | ﹤0.01% | 4863 |
|
2016
Q3 | – | Sell |
-2,000
| Closed | -$40K | – | 6901 |
|
2016
Q2 | $40K | Buy |
+2,000
| New | +$40K | ﹤0.01% | 4833 |
|